Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by PresidentBidenon Aug 05, 2020 6:52pm
159 Views
Post# 31369805

RE:RE:RE:Why the delay?

RE:RE:RE:Why the delay?Let's put things in perspective.  More money has been invested into a vaccine than ever before.  The vaccine will have to pass all safety aspects, but the question will be its efficacy.  The FDA has set a low bar in terms of efficacy, so it might be as low as 20%-30% effective, but let's hope for more.
All current vaccine candidates require 2 doses and the mRNA vaccines being produced by companies like Pfizer/Biontech and Moderna are required to be kept at -80 degrees Celsius.
Think of the logistics alone of transporting these vaccines. It will take 1-2 years to roll these vaccines out and by the time most healthy people are injected, it will easily be late 2021 or 2022.
This test is needed, but vaccines are coming and they will be used and most likely, it will be an annual vaccine that you'll need to take like the flu shot.
Bullboard Posts